No abstract available
MeSH terms
-
Humans
-
Immunologic Factors / adverse effects*
-
Immunologic Factors / therapeutic use
-
Interferon Type I / adverse effects*
-
Interferon Type I / therapeutic use
-
Leg
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
-
Male
-
Middle Aged
-
Motor Neurons / drug effects
-
Muscular Atrophy / chemically induced
-
Peripheral Nervous System Diseases / chemically induced*
-
Recombinant Proteins
Substances
-
Immunologic Factors
-
Interferon Type I
-
Recombinant Proteins